CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- DEF 14A Proxy Proxy Statement
- 10KSB Other 10KSB
- NT 10-K Other NT 10-K
- 10QSB Other 10QSB
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 10QSB Other 10QSB
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 10QSB Other 10QSB
- DEF 14A Proxy Proxy Statement
- 10KSB Other 10KSB
- 10QSB Other 10QSB
- 10QSB Other 10QSB
- 8-K Event Item 5
- SC 13G Stake Amended Statement of Ownership
- 10QSB Other 10QSB
- DEF 14A Proxy Proxy Statement
- 10KSB Other 10KSB
- 10QSB Other 10QSB
Page 67 of 68 · 1,360 filings